Average Co-Inventor Count = 4.87
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Eli Lilly and Company (16 from 4,447 patents)
2. Hoechst Marion Roussel (6 from 236 patents)
3. Merrell Pharmaceuticals, Inc. (6 from 194 patents)
4. Aventis Pharmaceuticals Inc. (4 from 207 patents)
5. Merrell Dow Pharmaceuticals (2 from 455 patents)
34 patents:
1. 11649247 - 7-phenylethylamino-4H-pyrimido[4,5-d][1,3]oxazin-2-one compounds as mutant IDH1 and IDH2 inhibitors
2. 11629156 - 7-phenylethylamino-4H-pyrimido[4,5-d][1,3]oxazin-2-one compounds as mutant IDH1 and IDH2 inhibitors
3. 11001596 - 7-phenylethylamino-4H-pyrimido[4,5-d][1,3]oxazin-2-one compounds as mutant IDH1 and IDH2 inhibitors
4. 10696665 - Mutant IDH1 inhibitors
5. 10253041 - 7-phenylethylamino-4H-pyrimido[4,5-d][1,3]oxazin-2-one compounds and their use as mutant IDH1 inhibitors
6. 9062050 - Inhibitor of JAK1 and JAK2
7. 8436002 - AKT inhibitors
8. 8058425 - Purine derivatives as kinase inhibitors
9. 7897600 - Amino pyrazole compound
10. 7666879 - Imidazo[1,2-A]pyridine compounds as VEGF-R2 inhibitors
11. 7405299 - Compounds as pharmaceutical agents
12. 7405305 - Pyrrole-2, 5dione derivatives and their used as GSK-3 inhibitors
13. 7045545 - Aminoalkylbenzofurans as serotonin (5-HT(2c)) agonists
14. 6967201 - Benzofurylpiperazines and benzofurylhomopiperazines: serotonin agonists
15. 6881733 - Serotonergic benzofurans